製品の概要

  • 製品名Anti-WBP1 antibody
    WBP1 一次抗体 製品一覧
  • 製品の詳細
    Goat polyclonal to WBP1
  • アプリケーション適用あり: IHC-Pmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Synthetic peptide: C-PAHFEGTNVE, corresponding to amino acids 165-174 of Human WBP1 (NP_036609.1).

  • ポジティブ・コントロール
    • Human Brain, Cerebellum and Human Pancreas tissue.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • バッファーpH: 7.30
    Preservative: 0.02% Sodium azide
    Constituents: 99% Tris buffered saline, 0.5% BSA
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab118511 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-P Use a concentration of 3.75 - 7.5 µg/ml.

ターゲット情報

  • 組織特異性Expressed in most tissues but at significantly lower levels in placenta, lung, liver, and kidney.
  • ドメインThe WW-binding 2 motif mediates interaction with WWOX. Both WW-binding motifs mediate interaction with NEDD4.
  • Information by UniProt
  • 参照データベース
  • 別名
    • WBP 1 antibody
    • WBP-1 antibody
    • WBP1 antibody
    • WBP1_HUMAN antibody
    • WW domain binding protein 1 antibody
    • WW domain-binding protein 1 antibody
    see all

Anti-WBP1 antibody 画像

  • ab118511 at 3.75 µg/ml staining WBP1 in Formalin-Fixed, Paraffin-Embedded Human Brain, Cerebellum tissue.
  • ab118511 at 3.75 µg/ml staining WBP1 in Formalin-Fixed, Paraffin-Embedded Human Pancreas tissue.

Anti-WBP1 antibody (ab118511) 使用論文

ab118511 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab118511.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"